NCT03009422

Fractional CO2 Laser With Topical Pentostam Treatment for Cutaneous Leishmaniasis.

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 20 (actual)
• Sponsor: Tel-Aviv Sourasky Medical Center · Other Government
• Sex: All
• Age: 18 Years – 60 Years
• Healthy volunteers: Accepted

Summary

The investigators will compare the common treatment for cutaneous leishmaniasis with intra-lesional Pentostam to fractional CO2 laser with topical application of Pentostam. Outcome will be final scar appearance assesd by two dermatologist and pain measurement by VAS.

Detailed description

20 healthy patients diagnosed will cutaneous leishmaniasis with more than one lesion will be recruited. Half of the lesions will be treated with intra-lesional injections of Pentostam, and the other half by CO2 laser with topical application of Pentostam. Each lesion will recieve 3 treatments, one month apart between treatments. The patients will scale pain level of each treatment. Final scar appearance will be assessed by two dermatologists, without knowing what treatment was applied to each lesion.

Conditions

• Leishmaniasis

Interventions

Type	Name	Description
DRUG	Local application pentostam
DRUG	intra-lisional pentostam
DEVICE	fractional CO2 laser

Timeline

• Start date: 2014-11-01
• Primary completion: 2017-02-01
• Completion: 2017-06-01
• First posted: 2017-01-04
• Last updated: 2017-01-04